Zymergen Inc. Common Stock
ZY was delisted on the 18th of October, 2022.
91 hedge funds and large institutions have $193M invested in Zymergen Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 12 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 23
0% more funds holding
Funds holding: 91 → 91 (0)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
19% less call options, than puts
Call options by funds: $452K | Put options by funds: $555K
57% less capital invested
Capital invested by funds: $450M → $193M (-$257M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$3.38M |
| 2 |
JP Morgan Chase
New York
|
+$2.58M |
| 3 |
Millennium Management
New York
|
+$2.02M |
| 4 |
Renaissance Technologies
New York
|
+$1.31M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Iconiq Capital
San Francisco,
California
|
-$6.63M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.56M |
| 4 |
Morgan Stanley
New York
|
-$3.31M |
| 5 |
BG
Bollard Group
Boston,
Massachusetts
|
-$2.68M |
ZY Hedge Fund Activity: Q1 2022 in Review
91 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Zymergen Inc. Common Stock (ZY) for Q1 2022, worth a combined $193M — down 57% from $450M a quarter earlier.
Fund positioning in ZY was balanced in Q1 2022: 12 funds opened new positions, 12 closed out, 32 added to existing stakes and 23 trimmed.
The largest buyer was Citigroup, adding an estimated $3.38M. The largest seller was Iconiq Capital, exiting entirely with an estimated $6.63M sold.
- 91 institutional investors held Zymergen Inc. Common Stock (ZY) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $193M of Zymergen Inc. Common Stock stock for Q1 2022, down 57% quarter-over-quarter.
- 12 funds opened new Zymergen Inc. Common Stock positions in Q1 2022 and 12 closed out, a net change of 0 holders.
- The largest Zymergen Inc. Common Stock buyer in Q1 2022 was Citigroup, an estimated $3.38M added.
- The largest Zymergen Inc. Common Stock seller in Q1 2022 was Iconiq Capital, an estimated $6.63M sold.
Based on aggregated 13F filings for Q1 2022.